Pharmacology of kinins: their relevance to tissue injury and inflammation.
D000595:Amino Acid Sequence; D000706:Anaphylatoxins / Q000032:analysis; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001249:Asthma / Q000503:physiopathology; D001920:Bradykinin / Q000494:pharmacology; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007249:Inflammation / Q000139:chemically induced; D007610:Kallikreins / Q000032:analysis; D007704:Kininogens / Q000032:analysis; D007705:Kinins / Q000032:analysis / Q000378:metabolism / Q000494:pharmacology*; D008070:Lipopolysaccharides / Q000494:pharmacology; D018002:Receptors, Bradykinin; D011956:Receptors, Cell Surface / Q000032:analysis; D014947:Wounds and Injuries / Q000503:physiopathology
D000706:Anaphylatoxins; D000806:Angiotensin-Converting Enzyme Inhibitors; D005338:Fibrin Fibrinogen Degradation Products; D007704:Kininogens; D007705:Kinins; D008070:Lipopolysaccharides; D018002:Receptors, Bradykinin; D011956:Receptors, Cell Surface; D007610:Kallikreins; D001920:Bradykinin